Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Barclays Maintains Equal-Weight on Biogen, Raises Price Target to $275

Barclays Maintains Equal-Weight on Biogen, Raises Price Target to $275

Barclays analyst Carter Gould maintains Biogen (NASDAQ:BIIB) with a Equal-Weight and raises the price target from $200 to $275.

byBenzinga Newsdesk

October 7, 2022

1 minute read

Barclays analyst Carter Gould maintains Biogen (NASDAQ:BIIB) with a Equal-Weight and raises the price target from $200 to $275.

News
Tech

NIO Announced Delivery of 10,059 Vehicles in October 2022

By Charles Gross

November 1, 5:38 AM

NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) ("NIO" or the "Company"), a pioneer and a leading company in the premium smart electric vehicle market, today announced its October 2022 delivery results.

NIO

Here’s How Much You Would Have Made Owning Hershey Stock In The Last 20 Years

By Benzinga Insights

July 14, 10:42 AM

Hershey (NYSE:HSY) has outperformed the market over the past 20 years by 2.41% on an annualized basis producing an average annual return of 10.39%. Currently, Hershey has a market capitalization of $44.43 billion.

HSY